Area of research
Pulmonary and Respiratory Medicine · Epidemiology
Research interest
Research focused on Bronchiectasis and Dysbiosis, with related work in Microvesicles, Exacerbation, Microbiome. Notable publications include 'Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium', 'European Respiratory Society clinical practice guideline for the management of adult bronchiectasis', and 'Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study'.
European Respiratory Society clinical practice guideline for the management of adult bronchiectasis
Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial
Upper-Airway Microbiome, Mucociliary Function, and Clinical Outcomes in Bronchiectasis: Data from the EMBARC-BRIDGE Study
Lower Airway and Oral Microbiome Dysbiosis in Patients with Long COVID Post-Hospitalisation: A UK Multicentre, Prospective Cohort Study
Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study
Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium